Bank of America’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Bank of America’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3,838	Closed	-$140K	–	7537
2016 Q4	$140K	Sell	3,838 -1,420	-27%	-$50.2K	﹤0.01%	5479
2016 Q3	$200K	Buy	+5,258	New	+$77.7K	﹤0.01%	5128
2016 Q2	–	Sell	-490	Closed	-$3K	–	7631
2016 Q1	$3K	Buy	+490	New	+$3.06K	﹤0.01%	6743

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Bank of America's CLCD Position: Q1 2017 in Review

Bank of America sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 3,838 shares — an estimated $140K sold.

Bank of America first reported a position in CLCD in Q1 2016 and held it in 3 quarters. The position peaked at $200K in Q3 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

Bank of America reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Bank of America sold 3,838 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $140K.
Bank of America first reported a position in CoLucid Pharmaceuticals, Inc. in Q1 2016 and held it in 3 quarters.
Bank of America's CoLucid Pharmaceuticals, Inc. position peaked at $200K in Q3 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Bank of America's 13F filing for Q1 2017, filed 15 May 2017.